DDR1 and cancer: Numerous studies have reported differential expression and mutations of DDR1 in several cancer types, clearly indicating that DDR1 can be considered a new player in different aspects of tumor progression [10,13], including metastatic spread, suppression of antitumor immunity [36], and modulation of cell response to chemotherapy [37,38,39].